drugset / Trial / NCT01523366
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to assess the pharmacodynamic effect of ticagrelor in Hispanic patients with stable coronary artery disease.
Timeline
- Start
- 2012-04
- Primary completion
- 2013-05
- Completion
- 2013-05
Outcome
Met primary endpoint
registry Ticagrelor Arm vs Clopidogrel Arm; p <.001; Mean Difference (Final Values) -167.2 (95% CI -197.0 to -137.4) NCT01523366 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | 75 mg | — |
| Subject | Ticagrelor | Small molecule | 90 mg | — |
| Subject | Ticagrelor | Small molecule | 180 mg | — |